Lead party: Anara Impact Capital (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Investor view in Meridian Capital
Target: Reme-D, Inc. (private company) · Sector: Healthcare, Medical Supplies, Biotechnology · Countries of operation: Sudan, Kenya, Egypt
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Ordinary Shares (Equity) · Round: Seed Extension / Pre-Series A · Deal amount: US$1.4m
Lead investor/buyer: Anara Impact Capital · Investors/buyers: Anara Impact Capital, Global Innovation Fund, Africa Health Ventures, Undisclosed Investors
Legal advisers: not identified in the source record.
Source: announced 24 July 2026. Original announcement: disruptafrica.com.


